Anti Human Immunodeficiency Virus type 1 (HIV-1) agents 4. Discovery of 5,5′-(p-Phenylenebisazo)-8-hydroxyquinoline sulfonates as new HIV-1 inhibitors in vitro

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 7, 2010, Pages 976-979

  Zeng, Xi Wen ^a   Huang, Ning ^b   Xu, Hui ^a   Yang, Wen Bin ^a   Yang, Liu Meng ^b   Qu, Huan ^a   Zheng, Yong Tang ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

8 hydroxyquinoline; Acquired immune deficiency syndrome; Human immunodeficiency virus 1; Inhibitor; Sulfonate

Indexed keywords

1,4 BENZENEDIAMINE; 5,5' (4 PHENYLENEBISAZO) 8 HYDROXYQUINOLINE 4 CHLOROBENZENESULFONATE; 5,5' (4 PHENYLENEBISAZO) 8 HYDROXYQUINOLINE 4 ETHYLBENZENESULFONATE; ANTIVIRUS AGENT; BENZENE DERIVATIVE; DIAMINE DERIVATIVE; QUINOLINOL DERIVATIVE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS REPLICATION; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; SYNTHESIS; TOXICITY; TUMOR CELL LINE;

ANTI-HIV AGENTS; CELL LINE, TUMOR; DRUG DISCOVERY; HIV-1; HUMANS; HYDROXYQUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77954291979     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.976     Document Type: Article

References (13)

1. Xu H., Lv M., Curr. Pharm. Des., 15, 2120-2148 (2009).
2. De Clercq E., Biochim. Biophys. Acta, 1587, 258-275 (2002).
3. Johnston M. I., Hoth D. F., Science, 260, 1286-1293 (1993).
4. Lambert J. S., Seidlin M., Reichman R. C., Plank C. S., Laverty M., Morse G. D., Knupp C., McLaren C., Pettinelli C., Valentine F. T., N. Engl. J. Med., 322, 1333-1340 (1990).
5. Yerly S., Kaiser L., Race E., Bru J. P., Clavel F., Perrin L., Lancet, 354, 729-733 (1999).
6. Abboud Y., Abourriche A., Saffaj T., Berrada M., Charrouf M., Bennamara A., Hannache H., Desalination, 237, 175-189 (2009).
7. Huang H., Kai F., Shoda T., Nakamura M., J. Coor. Chem., 28, 155-166 (1993).
8. Ingram A., Stokes R. J., Redden J., Gibson K., Moore B., Faulds K., Graham D., Anal. Chem., 79, 8578-8583 (2007).
9. Saran R., Baul T. S. B., Talanta, 41, 1537-1544 (1994).
10. Fan L. L., Liu W. Q., Xu H., Yang L. M., Lv M., Zheng Y. T., Chem. Pharm. Bull., 57, 797-800 (2009).
11. Dai H. L., Liu W. Q., Xu H., Yang L. M., Lv M., Zheng Y. T., Chem. Pharm. Bull., 57, 84-86 (2009).
12. Fan L. L., Liu W. Q., Xu H., Yang L. M., Lv M., Zheng Y. T., Lett. Drug Des. Discov., 6, 178-180 (2009).
13. Banerjie V., Dey A. K., Curr. Sci., 46, 778-779 (1977).